• 8 - 20 years
• Genders: both
• Key inclusion criteria: Primary diagnosis of OCD and currently on a stable and adequate dose of an SRI
Your child may be eligible to participate in this study if he/she is diagnosed with Obsessive-Compulsive Disorder.
• Lifetime diagnosis of: psychotic disorder, bipolar disorder, eating disorder, pervasive developmental disorder, mental retardation, or substance/alcohol dependence
• Current diagnosis of major depressive disorder, attention-deficit hyperactivity disorder (ADHD), Tourette’s/Tic Disorder, or substance/alcohol abuse
• Diagnosis of pediatric autoimmune neuropsychiatric disorders associated with streptococcus (PANDAS)
• Active Suicidal Ideation
• Hoarding as the primary OCD symptom
• Pregnant, nursing, or planning to become pregnant
This study aims to determine whether adding a medication called minocycline to
antidepressant treatment can help reduce symptoms of OCD. This study also aims to
learn more about the brains of children and adolescents with OCD.
Your child must be taking a stable dose of a serotonin reuptake inhibitor (SRI) in order to
participate in this study. During the 12 week study period, your child will continue to